Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
Clinical trial NCT01884675 · TERMINATED
Trial details
- NCT number
- NCT01884675
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.